For decades, drug developers have been confronted by the stubborn reality that most of the targets inside cells remain undruggable. Estimates suggest that as many as 85% of intracellular proteins ...

What hurdles in delivering new modalities, like biologics, are you seeing? Delivery is really the key. We know, if we conduct experiments in the laboratory on cells, we can get incredible results. We ...